Investigating the agreement of hypomagnesemia diagnosis based on three methods of serum , urine and red blood cells magnesium

Phase 2

Recruiting

• Conditions: Condition 1: Serum Magnesium. Condition 2: Red Blood Cell Magnesium. Condition 3: Urine Magnesium.; Abnormal level of blood mineral; R79.0

• Registration Number: IRCT20231220060484N3
• Lead Sponsor: Islamic Azad University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 27 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

At least 72 hours of placement in ICU
The patient's lack of hypermagnesium
Not receiving magnesium supplement at least in the past 72 hours
Absence of pregnancy and breastfeeding

Exclusion Criteria

The presence of kidney dysfunction (serum creatinine above 1.5 mg per dL)
Heart rate less than 60 per minute
Severe metabolic disorder
The patient is treated with diuretic drugs
Coagulopathy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Investigation of serum magnesium. Timepoint: At the beginning of the study. Method of measurement: End point colorimetric.;Investigation of red blood cell magnesium. Timepoint: At the beginning of the study. Method of measurement: Using the device ICP-OES.;Investigation of urine magnesium. Timepoint: At the end of collecting 24 hour urine. Method of measurement: By using the method MLT.